{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T06:21:37Z","timestamp":1785565297287,"version":"3.56.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["AI136581"],"award-info":[{"award-number":["AI136581"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["AI162633"],"award-info":[{"award-number":["AI162633"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008374","name":"Center for AIDS Research, Emory University","doi-asserted-by":"publisher","award":["P30-AI-050409"],"award-info":[{"award-number":["P30-AI-050409"]}],"id":[{"id":"10.13039\/100008374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jbc.2026.111409","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:02:13Z","timestamp":1774512133000},"page":"111409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["DNA-dependent RNA polymerase incorporates \u03b2-D-N4-hydroxycytidine (NHC) linking Molnupiravir to host transcription-dependent mutagenesis"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6274-8928","authenticated-orcid":false,"given":"Nathalie","family":"Garnier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond F.","family":"Schinazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7986-4335","authenticated-orcid":false,"given":"Baek","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.111409_bib1","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","article-title":"Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis","volume":"28","author":"Kabinger","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbc.2026.111409_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012574","article-title":"N4-Hydroxycytidine\/molnupiravir inhibits RNA virus-induced encephalitis by producing less fit mutated viruses","volume":"20","author":"Ojha","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jbc.2026.111409_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106286","article-title":"Inhibitors of pyrimidine synthesis synergize with N4-hydroxycytidine to diminish influenza virus replication","volume":"244","author":"Schrell","year":"2025","journal-title":"Antivir. Res"},{"key":"10.1016\/j.jbc.2026.111409_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/infdis\/jiab247","article-title":"\u03b2-d-N4-hydroxycytidine inhibits SARS-CoV-2 through lethal mutagenesis but is also mutagenic to mammalian cells","volume":"224","author":"Zhou","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jbc.2026.111409_bib5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41594-021-00657-8","article-title":"Molnupiravir: coding for catastrophe","volume":"28","author":"Malone","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbc.2026.111409_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100770","article-title":"Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template","volume":"297","author":"Gordon","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111409_bib7","doi-asserted-by":"crossref","first-page":"9403","DOI":"10.1021\/jm400653j","article-title":"Structure-activity relationships and design of viral mutagens and application to lethal mutagenesis","volume":"56","author":"Bonnac","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111409_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.omtn.2023.06.006","article-title":"Molnupiravir\u2019s mechanism of action drives \u201cerror catastrophe\u201d in SARS-CoV-2: a therapeutic strategy that leads to lethal mutagenesis of the virus","volume":"33","author":"Chatterjee","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jbc.2026.111409_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002214","article-title":"Evolutionary safety of lethal mutagenesis driven by antiviral treatment","volume":"21","author":"Lobinska","year":"2023","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jbc.2026.111409_bib10","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1073\/pnas.96.4.1492","article-title":"Lethal mutagenesis of HIV with mutagenic nucleoside analogs","volume":"96","author":"Loeb","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111409_bib11","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1128\/JVI.01624-06","article-title":"Theory of lethal mutagenesis for viruses","volume":"81","author":"Bull","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jbc.2026.111409_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.virusres.2004.11.011","article-title":"Lethal mutagenesis of HIV","volume":"107","author":"Smith","year":"2005","journal-title":"Virus Res."},{"key":"10.1016\/j.jbc.2026.111409_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01348-19","article-title":"Small-molecule antiviral \u03b2-d-N4-Hydroxycytidine inhibits a proofreading-intact coronavirus with a high genetic barrier to resistance","volume":"93","author":"Agostini","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.jbc.2026.111409_bib14","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41580-022-00476-9","article-title":"Structural insights into nuclear transcription by eukaryotic DNA-dependent RNA polymerases","volume":"23","author":"Girbig","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111409_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01719-19","article-title":"Analysis of the potential for N4 -Hydroxycytidine to inhibit mitochondrial replication and function","volume":"64","author":"Sticher","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jbc.2026.111409_bib16","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1007\/s00018-010-0346-2","article-title":"Retroviral reverse transcriptases","volume":"67","author":"Herschhorn","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jbc.2026.111409_bib17","doi-asserted-by":"crossref","first-page":"39380","DOI":"10.1074\/jbc.M110.178582","article-title":"Ribonucleoside triphosphates as substrate of human immunodeficiency virus type 1 reverse transcriptase in human macrophages","volume":"285","author":"Kennedy","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111409_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02395-16","article-title":"Characterization of \u03b2-d-N4-Hydroxycytidine as a novel inhibitor of chikungunya virus","volume":"61","author":"Ehteshami","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jbc.2026.111409_bib19","doi-asserted-by":"crossref","first-page":"51545","DOI":"10.1074\/jbc.M408573200","article-title":"Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase","volume":"279","author":"Diamond","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111409_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13059-018-1618-7","article-title":"An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar","volume":"20","author":"Grubaugh","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.jbc.2026.111409_bib21","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3390\/v1031137","article-title":"Mutation rates and intrinsic fidelity of retroviral reverse transcriptases","volume":"1","author":"Men\u00e9ndez-Arias","year":"2009","journal-title":"Viruses."},{"key":"10.1016\/j.jbc.2026.111409_bib22","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-023-06649-6","article-title":"A Molnupiravir-associated mutational signature in global SARS-CoV-2 genomes","volume":"623","author":"Sanderson","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111409_bib23","first-page":"4140","article-title":"Small-scale nuclear extracts for functional assays of gene-expression machineries","volume":"27","author":"Folco","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jbc.2026.111409_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2024.168690","article-title":"The HIV-1 transcriptional program: from initiation to elongation control","volume":"437","author":"D\u2019Orso","year":"2025","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jbc.2026.111409_bib25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.chom.2011.11.002","article-title":"The control of HIV transcription: keeping RNA polymerase II on track","volume":"10","author":"Ott","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jbc.2026.111409_bib26","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1073\/pnas.111085598","article-title":"RNA virus error catastrophe: direct molecular test by using ribavirin","volume":"98","author":"Crotty","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111409_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/narmme\/ugaf029","article-title":"Mechanism and spectrum of inhibition of viral polymerases by 2\u2032-deoxy-2\u2032-\u03b2-fluoro-4\u2032-azidocytidine or azvudine","volume":"2","author":"Lee","year":"2025","journal-title":"NAR Mol. Med."},{"key":"10.1016\/j.jbc.2026.111409_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105501","article-title":"Kill or corrupt: mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2","volume":"210","author":"Shannon","year":"2023","journal-title":"Antivir. Res"},{"key":"10.1016\/j.jbc.2026.111409_bib29","first-page":"5795","article-title":"Discovery, development, and patent trends on molnupiravir: a prospective oral treatment for COVID-19","volume":"26","author":"Imran","year":"2021","journal-title":"Mol. Basel Switz."},{"key":"10.1016\/j.jbc.2026.111409_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2024.199371","article-title":"Interaction and antiviral treatment of coinfection between SARS-CoV-2 and influenza in vitro","volume":"345","author":"Liu","year":"2024","journal-title":"Virus Res."},{"key":"10.1016\/j.jbc.2026.111409_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2025.110642","article-title":"The combinatorial activities of oseltamivir and molnupiravir against influenza virus infections in vitro and in vivo","volume":"611","author":"Feng","year":"2025","journal-title":"Virology"},{"key":"10.1016\/j.jbc.2026.111409_bib32","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1128\/AAC.48.12.4636-4642.2004","article-title":"Metabolism of the anti-hepatitis C virus nucleoside \u03b2- d - N4 -Hydroxycytidine in different liver cells","volume":"48","author":"Hernandez-Santiago","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jbc.2026.111409_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105858","article-title":"\u03b2-D-N4-hydroxycytidine (NHC, EIDD-1931) inhibits chikungunya virus replication in mosquito cells and ex vivo Aedes aegypti guts, but not when ingested during blood-feeding","volume":"225","author":"Rosales-Rosas","year":"2024","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jbc.2026.111409_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01965-17","article-title":"\u03b2-d-N4-Hydroxycytidine is a potent anti-alphavirus compound that induces a high level of mutations in the viral genome","volume":"92","author":"Urakova","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.jbc.2026.111409_bib35","article-title":"N4 -hydroxycytidine\/molnupiravir inhibits RNA-virus induced encephalitis by producing mutated viruses with reduced fitness","author":"Ojha","year":"2023","journal-title":"BioRxiv Prepr. Serv. Biol."},{"key":"10.1016\/j.jbc.2026.111409_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abl7430","article-title":"A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus","volume":"14","author":"Fischer","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2026.111409_bib37","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbc.2026.111409_bib38","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100043","article-title":"Phase 2\/3 trial of molnupiravir for treatment of Covid-19 in nonhospitalized adults","volume":"1","author":"Caraco","year":"2022","journal-title":"NEJM Evid."},{"key":"10.1016\/j.jbc.2026.111409_bib39","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1007\/s40121-023-00891-1","article-title":"Virologic outcomes with molnupiravir in non-hospitalized adult patients with COVID-19 from the randomized, placebo-controlled MOVe-OUT trial","volume":"12","author":"Strizki","year":"2023","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.jbc.2026.111409_bib40","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/cid\/ciad409","article-title":"Impact of molnupiravir treatment on patient-reported COVID-19 symptoms in the phase 3 MOVe-OUT trial: a randomized, placebo-controlled trial","volume":"77","author":"Guan","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jbc.2026.111409_bib41","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.7326\/M22-0729","article-title":"Effect of molnupiravir on biomarkers, respiratory interventions, and medical services in COVID-19 : a randomized, placebo-controlled trial","volume":"175","author":"Johnson","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jbc.2026.111409_bib42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(22)02597-1","article-title":"Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial","volume":"401","author":"Butler","year":"2023","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.jbc.2026.111409_bib43","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(22)01586-0","volume":"400","author":"Wong","year":"2022","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.jbc.2026.111409_bib44","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/cid\/ciac781","article-title":"Effectiveness of molnupiravir in high-risk patients: a propensity score matched analysis","volume":"76","author":"Najjar-Debbiny","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jbc.2026.111409_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13732","article-title":"Molnupiravir: mechanism of action, clinical, and translational science","volume":"17","author":"Maas","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.jbc.2026.111409_bib46","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100044","article-title":"Randomized trial of molnupiravir or placebo in patients hospitalized with Covid-19","volume":"1","author":"Arribas","year":"2022","journal-title":"NEJM Evid."},{"key":"10.1016\/j.jbc.2026.111409_bib47","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41467-024-45641-0","article-title":"Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients","volume":"15","author":"Standing","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111409_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/em.22471","article-title":"Human genetic risk of treatment with antiviral nucleoside analog drugs that induce lethal mutagenesis: the special case of Molnupiravir","volume":"63","author":"Waters","year":"2022","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.jbc.2026.111409_bib49","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1631\/jzus.B1400059","article-title":"Mechanism and factors that control HIV-1 transcription and latency activation","volume":"15","author":"Liu","year":"2014","journal-title":"J. Zhejiang Univ. Sci. B."},{"key":"10.1016\/j.jbc.2026.111409_bib50","first-page":"191","article-title":"RNA polymerase II transcription complex assembly in nuclear extracts","volume":"7","author":"Bral","year":"2018","journal-title":"Gene Expr."},{"key":"10.1016\/j.jbc.2026.111409_bib51","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/nar\/11.5.1475","article-title":"Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei","volume":"11","author":"Dignam","year":"1983","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111409_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104928","article-title":"Promoter-proximal nucleosomes attenuate RNA polymerase II transcription through TFIID","volume":"299","author":"Fisher","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111409_bib53","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0092-8674(02)00646-3","article-title":"The RNA polymerase II machinery: structure illuminates function","volume":"108","author":"Woychik","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.111409_bib54","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1016\/j.csbj.2023.09.001","article-title":"Current understanding of nucleoside analogs inhibiting the SARS-CoV-2 RNA-dependent RNA polymerase","volume":"21","author":"Xu","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.jbc.2026.111409_bib55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.semcdb.2014.03.030","article-title":"Cellular regulation of ribonucleotide reductase in eukaryotes","volume":"30","author":"Guarino","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.jbc.2026.111409_bib56","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/toxsci\/kfae112","article-title":"Comprehensive genotoxicity and carcinogenicity assessment of molnupiravir","volume":"202","author":"Escobar","year":"2024","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jbc.2026.111409_bib57","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1021\/acsptsci.4c00535","article-title":"Effective, but safe? Physiologically based pharmacokinetic (PBPK)-modeling-based dosing study of molnupiravir for risk assessment in pediatric subpopulations","volume":"7","author":"Mishra","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.jbc.2026.111409_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2025.128229","article-title":"Targeting HIV-1 immune escape mechanisms: key advances and challenges in HIV-1 vaccine design","volume":"299","author":"Fang","year":"2025","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.jbc.2026.111409_bib59","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41586-022-05538-8","article-title":"Phenotypic signatures of immune selection in HIV-1 reservoir cells","volume":"614","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111409_bib60","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/cimb47050367","article-title":"Mechanisms of immune evasion in HIV-1: the role of virus-host protein interactions","volume":"47","author":"Mouzakis","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.jbc.2026.111409_bib61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s44259-025-00125-z","article-title":"Strategies and efforts in circumventing the emergence of antiviral resistance against conventional antivirals","volume":"3","author":"Aw","year":"2025","journal-title":"Npj Antimicrob. Resist."},{"key":"10.1016\/j.jbc.2026.111409_bib62","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/jvi.59.2.284-291.1986","article-title":"Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone","volume":"59","author":"Adachi","year":"1986","journal-title":"J. Virol."},{"key":"10.1016\/j.jbc.2026.111409_bib63","article-title":"The galaxy platform for accessible, reproducible, and collaborative data analyses: 2024 update","volume":"52","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111409_bib65","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinforma. Oxf. Engl."},{"key":"10.1016\/j.jbc.2026.111409_bib66","article-title":"Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM","author":"Li","year":"2013","journal-title":"arXiv."},{"key":"10.1016\/j.jbc.2026.111409_bib67","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1016\/j.bmc.2016.03.052","article-title":"Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase","volume":"24","author":"Rawson","year":"2016","journal-title":"Bioorg. Med. Chem."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826002796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826002796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:39:23Z","timestamp":1779838763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826002796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0021925826002796"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111409","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA-dependent RNA polymerase incorporates \u03b2-D-N4-hydroxycytidine (NHC) linking Molnupiravir to host transcription-dependent mutagenesis","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"111409"}}